Many women entering their 40s and 50s describe a frustrating experience: The strategies that once supported their energy, sleep, and body composition suddenly seem less effective.

They’re still exercising and maintaining healthy nutritional habits. Yet fatigue becomes more common, cravings are harder to ignore, and weight distribution shifts in unfamiliar ways.

Increasingly, clinicians and researchers are paying closer attention to the relationship between hormones and inflammation as an important factor in women’s metabolic health as they age. Many midlife changes reflect a complex interaction between hormone fluctuations, immune signalling, insulin sensitivity, sleep quality, thyroid function, stress physiology, and lean muscle mass rather than lifestyle choices or reduced willpower.

Understanding those relationships and hormone therapy for women may help create more personalised strategies for long-term metabolic health.

What is inflammaging and why does it matter?

One term becoming increasingly common in longevity medicine is inflammaging.

Inflammaging describes the low-grade, persistent inflammatory activity that can gradually increase as we age. Unlike acute inflammation, which serves an important role in healing after injury or infection, inflammaging operates quietly in the background over months or years.

Researchers continue to investigate how this process contributes to changes in metabolism, recovery, cognitive function, and body composition. While much remains under investigation, evidence suggests that chronic inflammation and ageing may be closely connected through changes in immune regulation, cellular repair, and metabolic signalling.

Women experiencing inflammaging may notice symptoms such as:

• Reduced energy throughout the day
• Increased mental fog
• More difficulty recovering from exercise
• Sleep disturbances
• Mood changes
• Increased cravings
• Stubborn abdominal fat accumulation
• Reduced muscle tone despite regular activity

Because these symptoms often develop gradually, they are often dismissed as an unavoidable part of ageing.

The link between perimenopause and inflammation

Hormonal transitions may significantly influence inflammatory activity in women.

The relationship between perimenopause treatment and inflammation has become an important area of study as clinicians seek to better understand why metabolic changes often accelerate during midlife.

During perimenopause, oestrogen and progesterone levels fluctuate unpredictably before eventually declining. While these hormones are widely recognized for their reproductive functions, they also influence immune regulation, insulin sensitivity, vascular health, and body composition.

As hormone patterns become less stable, some women experience:

• Interrupted sleep
• Increased anxiety or irritability
• Greater difficulty maintaining muscle mass
• Reduced stress tolerance
• Increased hunger or cravings
• Brain fog
• Changes in fat distribution

For many women, the connection between perimenopause and inflammation may help explain why healthy routines no longer produce the same results they once did.

How metabolic inflammation changes the conversation

Traditional discussions surrounding metabolism often focus exclusively on calorie intake and exercise output.

But researchers increasingly recognise the role of metabolic inflammation in shaping how the body processes energy and regulates appetite.

Metabolic inflammation refers to inflammatory activity that interferes with normal metabolic signalling pathways. This can influence hunger cues, glucose utilisation, energy production, and patterns of fat storage.

Importantly, metabolic resistance does not necessarily indicate poor motivation or inadequate discipline.

Many women experiencing fatigue, increased cravings, or changes in body composition may actually be dealing with physiological adaptations occurring beneath the surface.

Viewing metabolism through an inflammatory lens allows for a more comprehensive understanding of these changes.

Understanding inflammation and insulin resistance in midlife

One of the most important metabolic relationships involves inflammation and insulin resistance.

Inflammatory signalling may reduce the body’s responsiveness to insulin over time, making it harder to regulate blood sugar effectively. Hormonal transitions can further influence this process, particularly when combined with poor sleep, chronic stress, or declining muscle mass.

Women experiencing changes in insulin sensitivity may notice:

• Increased appetite between meals
• Afternoon energy crashes
• Greater difficulty maintaining lean body mass
• More frequent cravings for carbohydrates
• Increased abdominal fat accumulation

The interaction between inflammation and insulin resistance highlights why a single laboratory marker rarely tells the entire story of metabolic health.

Why thyroid function, sleep, and stress matter

Hormones rarely operate in isolation.

Thyroid hormones influence energy production, body temperature regulation, recovery, and metabolic efficiency. Even subtle changes in thyroid function can affect how women feel day to day.

Sleep quality is another major contributor.

Poor sleep may increase inflammatory markers while also disrupting cortisol regulation, appetite hormones, and glucose metabolism. Women experiencing perimenopausal sleep disturbances may therefore encounter multiple overlapping challenges affecting energy and body composition.

Stress adds another layer of complexity.

Chronically elevated cortisol levels may influence immune function, insulin sensitivity, and inflammatory activity, creating a cycle that becomes increasingly difficult to break without addressing the underlying contributors.

Hormone optimisation for women requires a bigger picture

As understanding of midlife metabolism evolves, so does the approach to care.

Modern hormone optimisation for women increasingly focuses on understanding how hormone levels interact with inflammation, sleep, stress, nutrition, and body composition rather than evaluating a single laboratory value in isolation.

This broader perspective recognises that symptoms such as fatigue, brain fog, poor recovery, and changing body composition often arise from multiple interconnected systems.

A comprehensive evaluation may include:

• Sex hormones
• Thyroid markers
• Insulin regulation
• Body composition measurements
• Sleep quality assessments
• Inflammatory markers
• Lifestyle factors

This type of assessment helps clinicians identify patterns that might otherwise go unnoticed.

Female hormone optimisation is not one size fits all

The growing interest in optimising female hormones reflects a shift toward individualised medicine rather than standardised treatment protocols.

Women experience ageing differently based on genetics, lifestyle, stress exposure, sleep patterns, exercise habits, and existing metabolic health.

Because of these differences, personalised treatment plans often require ongoing reassessment and laboratory monitoring.

The goal is not simply symptom management. Instead, clinicians increasingly aim to support long-term function, resilience, and quality of life through a personalised approach to care.

What is hormone optimisation?

Patients frequently ask, “What is hormone optimisation?”

In simple terms, hormone optimisation is a personalised concierge medical weight-loss strategy that evaluates and addresses hormonal imbalances while considering the broader metabolic picture.

Rather than focusing solely on oestrogen or testosterone levels, modern approaches to hormone optimisation may include thyroid health, insulin regulation, inflammatory burden, muscle mass, sleep quality, and lifestyle factors.

The objective is not to reverse ageing or create unnaturally high hormone levels. Instead, treatment strategies are typically designed to help support energy, function, and overall well-being through individualised care plans.

Where does GLP-1 microdosing fit?

Only after evaluating these broader metabolic factors does it make sense to consider emerging therapeutic tools.

One area receiving growing attention is GLP-1 microdosing for women.

GLP-1 medications were originally developed to support glucose regulation and appetite signalling. More recently, some clinicians have explored lower-dose approaches that may support metabolic function in selected patients when clinically appropriate.

But GLP-1 microdosing should not be viewed as a standalone intervention for ageing or inflammation.

Research examining its relationship with inflammatory pathways remains an emerging area of study, and current evidence does not support claims that it reverses inflammaging or cures age-related metabolic dysfunction.

When utilised, these therapies should remain physician-guided, individualised, and supported by ongoing monitoring and laboratory evaluation.

A more complete view of women’s metabolic health

Women’s metabolic health is shaped by far more than calories consumed or hours spent exercising.

Hormones, sleep quality, muscle mass, thyroid function, stress exposure, insulin sensitivity, and inflammatory activity all influence how the body responds to ageing.

As our understanding of hormones and inflammation continues to evolve, clinicians are increasingly moving toward more comprehensive and personalised assessments that recognise the connections between these systems.

For many women, that shift may provide answers to symptoms that were previously attributed solely to ageing or lifestyle choices.

FAQs

• What is inflammaging? Inflammaging refers to the low-grade chronic inflammation that tends to increase with age and may influence metabolic health, recovery, and body composition.
• How are hormones and inflammation connected? Hormones influence immune activity and inflammatory signalling, while inflammation can also affect hormone production and receptor sensitivity.
• Can perimenopause increase inflammation? Research suggests that hormonal fluctuations during perimenopause may contribute to increased inflammatory activity in some women.
• How does inflammation affect women’s metabolism? Inflammation may influence insulin sensitivity, appetite regulation, energy production, and body composition.
• Can GLP-1 microdosing help with inflammation? GLP-1 microdosing remains an emerging area of research and should only be considered as part of a physician-guided, individualised metabolic strategy.
• When should women consider a comprehensive metabolic evaluation? Persistent fatigue, sleep disruption, cravings, changes in body composition, brain fog, or poor recovery may warrant a more comprehensive evaluation of hormones, thyroid function, insulin regulation, and inflammatory markers.

Sarah Malone, MSN, WHNP, is a women’s health nurse practitioner dedicated to providing compassionate, evidence based care to women across all stages of life. She combines clinical expertise with a strong commitment to patient education and preventive health.